Insiders · Profile

Vander Hoek Michael

Chief Financial Officer at Shuttle Pharmaceuticals. Filing since 29 Dec 2022. CIK 0001945351

Company
Date
Role
Action
Shares
Amount
Of holding
29 Dec 2022
Chief Financial Officer
Sold, plan not stated
2,243
$3.60K
36.8%
1 decision on file.